Cargando…

CXCL5 expression in tumor tissues is associated with poor prognosis in patients with pancreatic cancer

Immunotherapy based on the tumor microenvironment is a feasible method for treating cancer; therefore, it is necessary to investigate the immune microenvironment of pancreatic cancer and the influencing factors of the immune microenvironment. Chemokines are an important factor affecting the tumor im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Bin, Wang, Jing, Wang, Xiaoguang, Zhu, Mingyuan, Chen, Fei, Shen, Yiyu, Zhong, Zhengxiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509746/ https://www.ncbi.nlm.nih.gov/pubmed/32994820 http://dx.doi.org/10.3892/ol.2020.12120

Ejemplares similares

The prognostic value of intratumoral and peritumoral tumor-infiltrating FoxP3+Treg cells in of pancreatic adenocarcinoma: a meta-analysis
por: Hu, Lingyu, et al.
Publicado: (2021)

Effect of lymphadenectomy on the prognosis for N0 gallbladder carcinoma patients: A study based on SEER database
por: Wu, Bin, et al.
Publicado: (2021)

Long non-coding RNA AL137789.1 promoted malignant biological behaviors and immune escape of pancreatic carcinoma cells
por: Wang, Jing, et al.
Publicado: (2023)

Up-Regulated Maternal Embryonic Leucine Zipper Kinase Predicts Poor Prognosis of Hepatocellular Carcinoma Patients in a Chinese Han Population
por: Wu, Shaohan, et al.
Publicado: (2017)

Plasma lipid levels are associated with the CD8+ T‐cell infiltration and prognosis of patients with pancreatic cancer
por: Wu, Bin, et al.
Publicado: (2023)

CXCL5 overexpression predicts a poor prognosis in pancreatic ductal adenocarcinoma and is correlated with immune cell infiltration
por: Zhang, Ronghua, et al.
Publicado: (2020)

Neuroendocrine-like cells -derived CXCL10 and CXCL11 induce the infiltration of tumor-associated macrophage leading to the poor prognosis of colorectal cancer
por: Zeng, Yu-Jie, et al.
Publicado: (2016)

Risk Factors for Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis and the Effect of Octreotide Combined with Nonsteroidal Anti-Inflammatory Drugs on Preventing Its Occurrence
por: Wang, Jin, et al.
Publicado: (2018)

Clinical prognostic value of circulating tumor cells in the treatment of pancreatic cancer with gemcitabine chemotherapy
por: Wang, Xiaoguang, et al.
Publicado: (2021)

Over-expression of CXCL2 is associated with poor prognosis in patients with ovarian cancer
por: Zhang, Fenghua, et al.
Publicado: (2021)

Novel three-lncRNA signature predicts survival in patients with pancreatic cancer
por: Wu, Bin, et al.
Publicado: (2018)

CXCL12 expression in intrahepatic cholangiocarcinoma is associated with metastasis and poor prognosis
por: Miyata, Tatsunori, et al.
Publicado: (2019)

The expression and clinical prognostic value of protein phosphatase 1 catalytic subunit beta in pancreatic cancer
por: Hu, Lingyu, et al.
Publicado: (2021)

AMP-activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas
por: Xu, Haokai, et al.
Publicado: (2020)

Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma
por: Alafate, Wahafu, et al.
Publicado: (2020)

Homeobox B5 promotes metastasis and poor prognosis in Hepatocellular Carcinoma, via FGFR4 and CXCL1 upregulation
por: He, Qin, et al.
Publicado: (2021)

CXCL17 Expression Predicts Poor Prognosis and Correlates with Adverse Immune Infiltration in Hepatocellular Carcinoma
por: Li, Li, et al.
Publicado: (2014)

Elevated expression of CXCL16 correlates with poor prognosis in patients with colorectal cancer
por: Chen, Zhihui, et al.
Publicado: (2019)

Up-regulation of CXCL8 expression is associated with a poor prognosis and enhances tumor cell malignant behaviors in liver cancer
por: Yang, Song, et al.
Publicado: (2020)

The role of CXCL10 in prognosis of patients with colon cancer and tumor microenvironment remodeling
por: Song, Weiwei, et al.
Publicado: (2021)

CXCL5 Downregulation in Villous Tissue Is Correlated With Recurrent Spontaneous Abortion
por: Zhang, Sainan, et al.
Publicado: (2021)

The Chemokine CXCL7 Is Related to Angiogenesis and Associated With Poor Prognosis in Colorectal Cancer Patients
por: Li, Longhai, et al.
Publicado: (2021)

Upregulation of KLK8 Predicts Poor Prognosis in Pancreatic Cancer
por: Hua, Qing, et al.
Publicado: (2021)

CXCR2–CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma
por: Li, Li, et al.
Publicado: (2015)

Increased HMGB1 and cleaved caspase-3 stimulate the proliferation of tumor cells and are correlated with the poor prognosis in colorectal cancer
por: Zhang, Zhengxiang, et al.
Publicado: (2015)

High ROR2 expression in tumor cells and stroma is correlated with poor prognosis in pancreatic ductal adenocarcinoma
por: Huang, Jianfei, et al.
Publicado: (2015)

Overexpression of Chemokine (C-X-C) ligand 1 (CXCL1) associated with tumor progression and poor prognosis in hepatocellular carcinoma
por: Cao, Zhongwei, et al.
Publicado: (2014)

Downregulation of PGM5 expression correlates with tumor progression and poor prognosis in human prostate cancer
por: Sun, Jian, et al.
Publicado: (2022)

CXCL10 is a prognostic marker for pancreatic adenocarcinoma and tumor microenvironment remodeling
por: Nie, Yuan, et al.
Publicado: (2023)

CXCL13/CXCR5 Axis Predicts Poor Prognosis and Promotes Progression Through PI3K/AKT/mTOR Pathway in Clear Cell Renal Cell Carcinoma
por: Zheng, Zaosong, et al.
Publicado: (2019)

Overexpression of ERCC3 is associated with poor prognosis in patients with pancreatic cancer
por: Wang, Shujie, et al.
Publicado: (2021)

Co-expression of CXCL8 and HIF-1α is associated with metastasis and poor prognosis in hepatocellular carcinoma
por: Li, Xian-Peng, et al.
Publicado: (2015)

Elevated expression of Tiam1 is associated with poor prognosis and promotes tumor progression in pancreatic cancer
por: Ding, Mina, et al.
Publicado: (2018)

DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jianyu, et al.
Publicado: (2019)

ELK1 Enhances Pancreatic Cancer Progression Via LGMN and Correlates with Poor Prognosis
por: Yan, Qiang, et al.
Publicado: (2021)

CXCL5 and CXCL14, but not CXCL16 as potential biomarkers of colorectal cancer
por: Zajkowska, Monika, et al.
Publicado: (2023)

Downregulation of serum CXCL4L1 predicts progression and poor prognosis in prostate cancer patients treated by radical prostatectomy
por: Zhang, Mo, et al.
Publicado: (2019)

CXCL5 Has Potential to Be a Marker for Hepatocellular Carcinoma Prognosis and Was Correlating With Immune Infiltrates
por: Nie, Yuan, et al.
Publicado: (2021)

CXCL10/CXCR3 overexpression as a biomarker of poor prognosis in patients with stage II colorectal cancer
por: BAI, MING, et al.
Publicado: (2016)

CXCL16 positively correlated with M2-macrophage infiltration, enhanced angiogenesis, and poor prognosis in thyroid cancer
por: Kim, Min Joo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s3m7sfjc7o9d2i7uhh5o0jtl1j